BioCentury

7:00 AM GMT, Aug 18, 2014
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Status

Tirosint levothyroxine: Postmarketing study started

Akrimax Pharmaceuticals LLC (Cranford, N.J.) began the open-label,

Read the full 97 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.